title: Hemophagocytic lymphohistiocytosis after chemotherapy for multiple myeloma.
abstract: Secondary hemophagocytic lymphohistiocytosis has been reported after infections in immunocompromised hosts or in association with several malignancies. We report a case of secondary hemophagocytic syndrome after chemotherapy for multiple myeloma, which responded dramatically to dexamethasone, etoposide, and cyclosporin A.
authors.affiliation: University of Athens School of Medicine, Department of Clinical Therapeutics, Alexandra Hospital, Greece. iterr@otenet.gr
authors.forename: John V
authors.initials: JV
authors.lastname: Terrovitis
authors.forename: Charis
authors.initials: C
authors.lastname: Matsouka
authors.forename: Athanassios
authors.initials: A
authors.lastname: Anagnostopoulos
authors.forename: Maria I
authors.initials: MI
authors.lastname: Anastasiou-Nana
authors.forename: Athanassios Meletios
authors.initials: AM
authors.lastname: Dimopoulos
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001707:Biopsy, Needle; D001853:Bone Marrow / Q000473:pathology; D016572:Cyclosporine / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D015616:Histiocytosis, Non-Langerhans-Cell / Q000139:chemically induced* / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D005047:Etoposide; D003907:Dexamethasone; D016572:Cyclosporine